Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report25 March 2024
Urenco has broken ground on a project which will help it deliver global energy security for years to come.
The ceremony took place at Urenco’s Netherlands site in Almelo on Monday, March 25.
The extension project, which comes under our existing capacity programme, will see multiple new centrifuge cascades added to an existing plant, strengthening the nuclear fuel supply chain. The first cascades are due to come online in 2027.
Ad Louter, Urenco Almelo Managing Director, said: “Urenco takes the needs of the market incredibly seriously. This project will help deliver 1.6 million SWU in total alongside other projects happening at our sites in Germany and the USA.
“Energy security and decarbonisation have never been so important as they are today, and we are in a time of great change for nuclear without which it will be impossible to meet ambitious climate targets.”
The capacity programme is a mid to long term plan to refurbish and extend Urenco’s enrichment capacity at all of its four sites.
It comes as more countries and utility companies turn to nuclear for the first time, or seek to extend and/or diversify fuel supplies for existing nuclear operations.
New commitments from customers underpin this investment.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries